Quarterly Result14 Aug 2025, 05:37 pm
Gennex Laboratories Ltd. Reports Q1 2025 Financial Results with 40.33% YoY Revenue Growth
AI Summary
Gennex Laboratories Ltd. has announced its unaudited standalone and consolidated financial statements for the quarter ended June 30, 2025. The company's revenue from operations stands at INR 3,417.75 million, representing a 40.33% year-over-year growth. The total income for the quarter is INR 3,645.49 million, while the total expenses amount to INR 2,790.44 million, leading to a profit before exceptional items and tax of INR 855.05 million. The company's net profit for the period attributable to owners of the parent is INR 607.00 million, and the earnings per share (EPS) is INR 0.607. The Board of Directors approved the financial results in their meeting on August 14, 2025.
Key Highlights
- Revenue from operations for Q1 2025 stands at INR 3,417.75 million, a 40.33% YoY growth.
- Total income for the quarter is INR 3,645.49 million.
- Total expenses for the quarter amount to INR 2,790.44 million.
- Profit before exceptional items and tax for the quarter is INR 855.05 million.
- Net profit attributable to owners of the parent for the quarter is INR 607.00 million.